from above in dry CH2Cl2 (10 mL). The mixture was then stirred
for another 18 h and quenched through the addition of phosphate
pH 7 buffer solution (15 mL), MeOH (15 mL), and 30% H2O2
(7.5 mL). After stirring for 30 min at room temp, the mixture was
poured onto saturated aq NaHCO3 and worked up (extraction with
CH2Cl2). Column chromatography of the oily residue on silica gel
(hexanes-EtOAc, 4:1) yielded 11 (1.19 g, 70% overall from 10):
amorphous solid; [R]D +3.4 (c 2, CHCl3).1H NMR (500 MHz,
CDCl3): δ 7.75-7.70 (4H, m), 7.50-7.20 (16H, br m), 5.64 (1H,
d, J ) 6.9 Hz), 4.77 (1H, quint, J ) 6.9 Hz), 4.45 (1H, d, J ) 11.3
Hz), 4.27 (1H, d, J ) 11.3 Hz), 4.14 (1H, m), 3.92 (1H, m), 3.79
(1H, m), 3.68 (1H, m), 1.75-1.70 (3H, m), 1.60-1.50 (4H, m),
1.25 (3H, d, J ) 6.9 Hz), 1.10 (3H, d, J ) 6.3 Hz), 1.09 (9H, s),
0.90 (3H, d, J ) 6.3 Hz). 13C NMR (125 MHz): δ 177.1, 152.6,
138.8, 134.8, 134.3, 133.2, 19.3 (C), 135.9, 135.8, 129.5, 129.4,
128.7, 128.6, 128.2, 127.6, 127.5, 127.4, 125.6, 78.9, 76.1, 71.7,
67.3, 54.8, 42.5 (CH), 70.7, 44.9, 30.1, 29.2 (CH2), 27.1 (x 3),
24.4, 14.3, 10.6 (CH3). IR νmax: 3500 (br, OH), 1782, 1698 (CdO)
cm-1. HR FAB MS m/z: 708.3755 (M + H+). Calcd for C43H54-
NO6Si, 708.3720.
Oxazolidinone 12. Oxazolidinone 11 (1.06 g, 1.5 mmol) was
dissolved in dry CH2Cl2 (20 mL) and treated sequentially with 2,6-
lutidine (875 µL, 7.5 mmol) and TBSOTf (1.38 mL, 6 mmol). The
reaction mixture was then stirred for 1 h at room temp and worked
up (extraction with CH2Cl2). Column chromatography on silica gel
(hexanes-EtOAc, 19:1) afforded the desired 12 (1.05 g, 85%): oil;
[R]D +6.8 (c 1.5, CHCl3). 1H NMR (500 MHz, CDCl3): δ 7.75-
7.70 (4H, m), 7.50-7.20 (16H, br m), 5.49 (1H, d, J ) 7 Hz),
4.62 (1H, quint, J ) 7 Hz), 4.44 (1H, d, J ) 11 Hz), 4.24 (1H, d,
J ) 11 Hz), 4.14 (1H, m), 4.06 (1H, m), 3.89 (1H, m), 3.65 (1H,
m), 1.75-1.60 (6H, m), 1.21 (3H, d, J ) 6.8 Hz), 1.10 (3H, d, J
) 6.3 Hz), 1.09 (9H, s), 0.94 (9H, s), 0.90 (3H, d, J ) 6.5 Hz),
0.09 (3H, s), 0.08 (3H, s). 13C NMR (125 MHz): δ 175.1, 152.6,
138.9, 134.8, 134.3, 133.2, 19.2, 18.0 (C), 135.9, 135.8, 129.5,
129.4, 128.6, 128.5, 128.2, 127.6, 127.5, 127.4, 125.6, 78.7, 76.5,
73.3, 67.3, 55.2, 42.8 (CH), 70.7, 45.2, 30.9, 29.2 (CH2), 27.1 (x
3), 25.9 (x 3), 24.4, 14.1, 12.2, -4.1, -4.8 (CH3). IR νmax: 1783,
1705 (CdO) cm-1. HR EIMS m/z (% relative intensity): 764.3784
(M+-tBu, 1), 656 (2), 199 (56), 91 (100). Calcd for C49H67NO6-
Si2-tBu, 764.3802.
(2R,3S,6S,8S)-6-Benzyloxy-3-(tert-butyldimethylsilyloxy)-8-
(tert-butyldiphenylsilyloxy)-2-methylnonanoic Acid (13). Com-
pound 12 (1.05 g, 1.27 mmol) from above was dissolved in a 2:1
THF/H2O mixture (20 mL) and treated with lithium hydroxide
monohydrate (105 mg, 2.5 mmol) and 30% aq H2O2 (0.8 mL). The
mixture was stirred at room temp for 24 h and poured onto 1.6 M
Na2SO3, followed by workup (extraction with CH2Cl2). Column
chromatography on silica gel (hexanes-EtOAc, 4:1) afforded acid
13 (644 mg, 76%): oil; [R]D -3 (c 2, CHCl3). 1H NMR (500 MHz,
CDCl3): δ 7.70-7.65 (4H, m), 7.50-7.20 (11H, br m), 4.40 (1H,
d, J ) 11.3 Hz), 4.24 (1H, d, J ) 11.3 Hz), 4.12 (1H, sext, J ) 6
Hz), 4.00 (1H, dt, J ) 4.5, 6 Hz), 3.60 (1H, quint, J ) 5.5 Hz),
2.59 (1H, dq, J ) 4.5, 7 Hz), 1.68 (2H, m), 1.60-1.50 (4H, m),
1.40 (1H, m), 1.14 (3H, d, J ) 7 Hz), 1.10 (3H, d, J ) 6 Hz), 1.07
(9H, s), 0.91 (9H, s), 0.09 (3H, s), 0.08 (3H, s). 13C NMR (125
MHz): δ 178.7, 138.8, 134.8, 134.3, 19.3, 18.0 (C), 135.9, 135.8,
129.6, 129.5, 128.3, 127.6, 127.5, 127.4, 76.3, 73.7, 67.3, 44.3 (CH),
70.8, 45.1, 29.9, 29.5 (CH2), 27.1 (x 3), 25.8 (x 3), 24.5, 10.9,
-4.3, -4.8 (CH3). IR νmax: 3500-2500 (br, COOH), 1708 (Cd
O) cm-1. HR EIMS m/z (% relative intensity): 605.3142 (M+-
tBu, 1), 497 (8), 199 (46), 91 (100). Calcd for C39H58O5Si2-tBu,
605.3118.
FIGURE 2. The structures of (-)-nonactic acid (18) and (+)-
homononactic acid (19).
weight and C/H atom connectivity. Furthermore, both would
show the NOE between H-3 and H-6 reported for feigrisolide
A.1 Structure 18 for feigrisolide A would also explain the
formation of a monoacetylated derivative, instead of the
expected diacetate. A direct comparison of feigrisolide A and
nonactic acid was not possible, because of the nonavailability
of authentic samples of the natural compounds. Moreover,
accurate, high-resolution 1H and 13C NMR data of free nonactic
acid have not been reported in the literature.14 Fortunately, these
data were sent to us by Prof. Eun Lee (see acknowledgments).4
After comparison with the NMR data of feigrisolide A (see the
Supporting Information), we have been able to conclude that
feigrisolide A is identical with 18. Structure 1 therefore does
not correspond to any natural product reported to date.
Following the same line of reasoning disclosed above,
feigrisolide B should correspond to the right half of the structure
of feigrisolide C and be thus identical with the known compound
(+)-homononactic acid 19 (Figure 2).15 High-resolution 1H and
13C NMR data of 19 were also sent to us by Prof. E. Lee.
Comparison with those of feigrisolide B (see Supporting
Information) leads to the conclusion that both compounds are
identical. This explains the failure of the previous attempt by
Sharma and Kumar3 at synthesizing feigrisolide B.
Conclusions
We have performed a stereoselective synthesis of the structure
published for the natural compound named feigrisolide A. It
has been found that the published structure does not correspond
to that of the natural product. A revised structure is proposed
not only for feigrisolide A but also for the closely related
feigrisolide B.
Experimental Section
General Features and Reaction Conditions. Described in the
Supporting Information.
Oxazolidinone 11. DMSO (0.42 mL, 6 mmol) was dissolved in
dry CH2Cl2 (6 mL), cooled to -78 °C and treated with oxalyl
chloride (265 µL, ca. 3 mmol). After stirring at this temp for 5
min, a solution of 10 (1.15 g, 2.4 mmol) in dry CH2Cl2 (2 mL)
was added dropwise, followed by triethylamine (1.7 mL, ca. 12
mmol). The reaction mixture was stirred for 15 min at -78 °C and
then for another 60 min at 0 °C. Workup (extraction with CH2Cl2)
and evaporation in vacuo provided a crude aldehyde which was
directly used in the next step.
A solution of oxazolidinone 14 (2.33 g, 10 mmol) in dry CH2-
Cl2 (20 mL) was cooled to 0 °C and treated sequentially with a 1
M solution of Bu2BOTf in CH2Cl2 (11 mL, 11 mmol) and
triethylamine (1.8 mL, ca. 13 mmol). The mixture was then stirred
for 1 h, followed by the addition of a solution of the crude aldehyde
(2R,3S,6S,8S)-3-(tert-Butyldimethylsilyloxy)-8-(tert-butyldiphen-
ylsilyloxy)-6-hydroxy-2-methylnonanoic Acid (14). An amount
of 10% Pd/C (300 mg) was suspended in EtOAc (5 mL) under an
H2 atmosphere. Acid 13 (630 mg, 0.95 mmol) dissolved in EtOAc
(15 mL) was then added via syringe. The mixture was stirred at
room temp and ambient pressure for 2 h and then filtered through
(14) We have only found 1H NMR data of (+)-nonactic acid: Fraser,
B.; Perlmutter, P. J. Chem. Soc., Perkin Trans. 1 2002, 2896-2899.
(15) (a) Schmidt, U.; Werner, J. Synthesis 1986, 986-992. (b) Kiyota,
H.; Abe, M.; Ono, Y.; Oritani, T. Synlett 1997, 1093-1095. See also the
following: Stadler, M.; Bauch, F.; Henkel, T.; Mu¨hlbauer, A.; Mu¨ller, H.;
Spaltmann, F.; Weber, K. Arch. Pharm. 2001, 334, 143-147.
5768 J. Org. Chem., Vol. 71, No. 15, 2006